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Cohort studies and facility-based sentinel surveillance are common approaches to characterizing infectious disease burden, but pres-
ent trade-offs; cohort studies are resource-intensive and may alter disease natural history, while sentinel surveillance underestimates 
incidence in the population. Hybrid surveillance, whereby facility-based surveillance is paired with a community-based healthcare 
utilization assessment, represents an alternative approach to generating population-based disease incidence estimates with moder-
ate resource investments. Here, we discuss this method in the context of the Surveillance for Enteric Fever in Asia Project (SEAP) 
study. We describe how data are collected and utilized to adjust enteric fever incidence for blood culture sensitivity, facility-based 
enrollment, and healthcare seeking, incorporating uncertainty in these parameters in the uncertainty around incidence estimates. 
We illustrate how selection of surveillance sites and their coverage may influence precision and bias, and we identify approaches in 
the study design and analysis to minimize and control for these biases. Rigorously designed hybrid surveillance systems can be an 
efficient approach to generating population-based incidence estimates for infectious diseases.
Keywords. typhoid; enteric fever; surveillance; incidence; methods; bias.
 
Enteric fever, an invasive infection with Salmonella Typhi or 
Paratyphi, is estimated to be the cause of more than 15 mil-
lion illnesses and 150 000 deaths annually, the vast majority 
of which occur in low- and middle-income countries [1–3]. 
The World Health Organization recently prequalified a new 
typhoid conjugate vaccine (TCV) and issued a recommenda-
tion that TCVs be utilized in the prevention of typhoid and 
to be prioritized in countries with the highest burden of dis-
ease [4]. However, the majority of countries where typhoid is 
believed to be endemic lack recent and geographically repre-
sentative data on typhoid incidence. This may represent an 
obstacle to introducing typhoid vaccines, including decision 
making concerning which countries or subnational regions 
to prioritize, as well as assessment of their impact on disease 
burden.
The most rigorous form of infectious disease burden esti-
mation is a prospective, community-based cohort study. This 
form of study, commonly used for vaccine trials, involves 
recruitment of healthy participants in the community who 
are followed closely for the development of incident typhoid 
fever. Because individuals with typhoid often seek medical care 
within days of symptom onset, studies often involve contact-
ing each participant 2–3 times weekly to assess for the devel-
opment of fever, followed by diagnostic testing for those who 
report fever. As the incidence of typhoid is typically <1% per 
year, typhoid cohort studies typically involve enrolling tens of 
thousands of participants, which is costly and requires substan-
tial research infrastructure [5–7]. Consequently, this approach 
is relegated largely to short-term research studies and is not a 
sustainable approach to disease surveillance. Additionally, by 
actively contacting participants, diagnoses are typically made 
early in the disease course, prompting therapy that averts 
severe sequelae. This may alter the spectrum of disease toward 
more mild cases, which may not be representative of the sever-
ity of illness that may be seen in the absence of surveillance. 
For these reasons, cohort studies may be less attractive for 
assessing vaccine effectiveness.
A more common surveillance approach is ascertainment of 
cases presenting to healthcare facilities. This can be done retro-
spectively or prospectively, assessing culture positivity among 
patients meeting a suspected case definition. This approach 
requires fewer resources and, unlike cohort studies, may cap-
ture more severe cases as they are more likely to seek care. The 
major drawback to this method is that it leads to substantial 
underestimation of the population burden of disease, as only 
a fraction of all typhoid patients seek care at hospital surveil-
lance sites. Indeed, the majority of individuals with acute febrile 
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illness in typhoid-endemic countries seek care primarily at 
pharmacies and medical shops, where blood culture capacity is 
usually not available [8, 9].
There is therefore a gap between cohort studies, which 
achieve direct population-level estimates of generally mild 
infections and are resource intensive, and facility-based surveil-
lance, which is inexpensive and underestimates incidence but 
captures the more severe outcomes that are likely to motivate 
interventions. A  more recently developed approach between 
these extremes involves pairing facility-based surveillance with 
population-based healthcare utilization surveys, which we refer 
to as “hybrid surveillance.” Hybrid surveillance, which has 
been employed for a number of infectious diseases including 
typhoid, enables the generation of population-based incidence 
estimates with considerably fewer resource requirements than 
cohort studies [10–12]. We have utilized hybrid surveillance 
in phase 2 of the Surveillance of Enteric Fever in Asia Project 
(SEAP), an ongoing study that aims to estimate typhoid inci-
dence, clinical spectrum, outcomes, and costs in Bangladesh, 
Pakistan, and Nepal.
While previous studies and a review have provided an over-
view of the methods for hybrid surveillance data collection and 
analysis [10, 11, 13], they have not addressed how to incorpo-
rate uncertainty of various components or provided detailed 
considerations for the design of reliable surveillance systems. In 
this article, we describe methods used for hybrid surveillance, 
including considerations concerning surveillance site selection, 
sample size, and statistical approaches to incorporating uncer-
tainty in various components of this model. We highlight key 
assumptions underlying this approach and discuss difficulties 
and potential for biases, as well as new methods for bias correc-
tion. The methods described here were developed in the context 
of enteric fever surveillance, but may have broader applicability 
to surveillance for other diseases.
HYBRID SURVEILLANCE FRAMEWORK AND 
COMPONENTS
Hybrid surveillance may be thought of as characterizing the lay-
ers of a disease detection pyramid, where all typhoid patients 
within a catchment area represent the base, and culture-con-
firmed cases detected at surveillance facilities represent the apex 
(Figure 1). A fraction of all typhoid patients in the community 
will seek care at study sites, a proportion of those are recruited 
and enrolled into the surveillance system, and the sensitivity 
of blood culture will determine how many cases are detected 
among those enrolled. Hybrid surveillance involves adjusting 
cases detected for these factors. Here, we describe the overall 
surveillance approach, including how each of these parameters 
is estimated, and then describe how these estimates are utilized 
to generate incidence estimates.
First, the overall study population must be identified, usu-
ally in a geographically circumscribed area. It is possible to first 
identify an area of interest, and then choose commonly utilized 
healthcare facilities within that area to establish surveillance, but 
often the surveillance sites with the capacity for microbiological 
diagnoses are identified first and the catchment area is subse-
quently characterized. The catchment area of a health facility 
generally depends on the disease of interest, with more severe 
conditions having a larger catchment area for a well-resourced 
facility; as a result, the catchment should area be defined with 
respect to the disease that is being studied. Importantly, sur-
veillance catchment areas are not drawn to identify the entire 
geographic expanse of patients’ homes who utilize these facil-
ities. Rather, catchments for surveillance are drawn by the 
Culture
Sensitivity (A3)
Crude Incidence =
Culture-Positive Cases
Crude Incidence
A1 × A2 × A3
Population × Time
Adjusted Incidence =
Culture
Positive
Blood Culture Performed
Sought Care at Study Site
All Typhoid Patients
Enrollment
Capture (A2)
Facility
Coverage (A1)
Figure 1. Typhoid disease pyramid, where the base represents all typhoid patients in a catchment area and the apex represents culture-positive cases detected at study 
sites. Culture sensitivity is estimated from the literature, enrollment capture is estimated at facilities, and facility coverage is estimated by a household survey. These factors 
are utilized to adjust the crude incidence.
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surveillance team to optimize measurement of incidence. For 
the SEAP phase 2 studies, the catchment areas were constructed 
by mapping either suspected or culture-confirmed typhoid 
cases from selected sentinel surveillance sites in recent years. 
After mapping cases, geographical boundaries are identified 
that contain the majority of cases and represent well-recognized 
administrative boundaries (eg, city ward), enabling patients 
presenting to facilities to easily identify whether they live within 
the study catchment.
After the catchment area has been specified, healthcare uti-
lization in that population is assessed by means of a household 
survey. This is often done concomitantly with facility-based 
surveillance. In the SEAP study, a multistage, cluster design 
was utilized to select a representative subset of all households 
in the catchment area for survey. The questionnaire focuses on 
whether any individuals in the household met a simple, stan-
dardized definition for suspected enteric fever (fever ≥3 days) 
within a time period in which recall is expected to be reliable 
(past 8 weeks). As recall regarding hospitalization is thought to 
be reliable for a longer recall period, additional questions are 
asked about hospitalization within the past year for febrile ill-
ness. Questions concerning severity of the febrile illness, demo-
graphics, household assets, and water source are asked to enable 
adjustments for differences in populations who seek care at the 
study site and those who do not, as described below. This survey 
may also be used to estimate the population size and age struc-
ture for the catchment area, if recent census data corresponding 
to that area are not available.
Additionally and typically concomitantly, facility-based sur-
veillance for enteric fever is established at one or more sentinel 
sites within the catchment area. Patients seeking care at sen-
tinel sites who meet study inclusion criteria are recruited and 
offered enrollment into the study. For the SEAP study, enroll-
ment criteria are as follows: an individual, residing within the 
catchment area, who presents to the outpatient or emergency 
department with fever for ≥3 consecutive days within the past 
week. A blood culture is offered to all enrolled individuals, and 
confirmed enteric cases are defined as individuals with a blood 
culture positive for typhoidal Salmonella. Even under study con-
ditions, not all individuals presenting to sentinel sites who meet 
the enrollment criteria will be enrolled, due to missed cases (eg, 
when research staff are not present), difficulties with collecting 
blood, or declined consent. Logs are utilized to record the num-
bers of eligible patients who were not enrolled, to enable adjust-
ment for this missing proportion. Systematic random sampling 
(eg, enrolling every fifth eligible patient, or enrolling every 
other day) may also be performed if resources are constrained, 
though care must be taken to ensure that sampling remains sys-
tematic and selection biases are not introduced.
The final adjustment factor accounts for the sensitivity of the 
diagnostic; for enteric fever, blood culture remains the primary 
reference standard due to nearly perfect specificity and the lack 
of highly specific alternative diagnostics [14]. Estimates for the 
sensitivity of blood culture are derived from published litera-
ture, predominantly studies in which bone marrow culture (a 
highly sensitive and specific approach, but unsuitable for large-
scale surveillance due to its invasive nature) was performed. 
A recent meta-analysis reported a composite estimate of 61% 
(95% confidence interval [CI], 52%–70%) [15]. Multiple factors 
influence the sensitivity of blood culture including the duration 
of fever prior to collection, recent antibiotic use, blood volume 
collected, and the culture media, including use of antibiotic 
binding resins. Ongoing work is aimed at characterizing the 
influence of these parameters, which could enable better esti-
mates for culture sensitivity according to these factors at each 
study site.
ESTIMATING INCIDENCE FROM HYBRID 
SURVEILLANCE
Crude incidence estimates from facility-based surveillance 
are derived by dividing the total number of culture-con-
firmed enteric fever cases by the product of the population and 
time: 
Crude Incidence Cases
Population Time
=
×
Adjusted incidence can be estimated by dividing the crude inci-
dence by the 3 adjustment factors: 
AdjustedIncidence
Crude Incidence
A A A
=
× ×1 2 3
Here, A1 is the proportion of individuals in the community 
meeting the case definition who seek care at the study site 
(“facility coverage”), A2 is the proportion of patients presenting 
to the facility and meeting the case definition who are enrolled 
(“enrollment capture”), and A3 is the sensitivity of culture. In 
some situations, partially adjusted incidence estimates, in which 
not all factors are adjusted for, may be of interest. For example, 
if there is concern about biases in healthcare utilization, esti-
mates that adjust only for culture sensitivity and facility-based 
enrollment may be desired, to provide a minimum estimate for 
disease incidence. Estimates are often presented with stratifica-
tion by age, using age-specific case counts, catchment popula-
tion, and adjustors.
To characterize uncertainty in incidence while reflecting the 
uncertainty in each of these adjustments, we perform Monte 
Carlo sampling from distributions of cases (binomial) and 
adjustment factors (beta). When population size is estimated 
directly from the healthcare utilization survey, rather than cen-
sus estimates, uncertainty in population size may be incorpo-
rated into the model.
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FACILITY COVERAGE AND SAMPLE SIZE
The proportion of patients with enteric fever who seek care at 
the surveillance sites (“facility coverage”) is a critical determi-
nant of uncertainty in incidence estimates. Smaller facility cov-
erage fractions require substantially larger healthcare utilization 
surveys to achieve equivalent precision in incidence estimates. 
To illustrate this, we simulate a hypothetical community with a 
population of 500 000 and an annual enteric fever incidence of 
2500 cases (500 per 100 000). We vary the proportion that pres-
ent to surveillance sites (10%, 25%, 50%) and assume that care 
seeking is binomially distributed. We compare precision of inci-
dence estimates according to effective sample size (households 
with a participant meeting the fever definition in past 8 weeks 
and cluster adjusted sample) for each of these 3 facility-based 
capture rates (Figure  2), ignoring uncertainty introduced by 
culture sensitivity at this time.
For communities in which 50% of individuals with suspected 
enteric fever seek care at the study sites, relative precision of 
±10% (95% CI, 450–550 per 100 000) can be achieved by an 
effective sample size of 550 households. By contrast, commu-
nities in which 25% and 10% of individuals seek care at study 
sites would have errors of ±27% and 34%, respectively, at that 
same sample size. Achieving ±10% error would require an effect 
sample size of 2500 for communities with 25% seeking care at 
study sites; this ±10% error rate would not be possible for com-
munities with 10% seeking care at study site. The error does 
not approach 0 because of the remaining uncertainty in the 
numerator. For an equivalent population size, a lower propor-
tion of individuals seeking care at the study site results in fewer 
enrolled cases and a larger degree of uncertainty around crude 
rates. In other words, lower facility coverage results in greater 
uncertainty in both the numerator (cases, which are fewer when 
this proportion is low) and the multiplier. A larger healthcare 
utilization survey can offset the latter, but a longer study (to 
enroll more cases) is required to offset the former.
ADDRESSING POTENTIAL BIASES
The hybrid surveillance pyramid has all typhoid patients as the 
base, and the second level are those that seek care at the study 
sites. The key multiplier here is the proportion of all typhoid 
patients who seek care at the study sites; however, what is mea-
sured by the healthcare utilization survey is the proportion of 
individuals meeting a typhoid suspect case definition (fever 
≥3 days) who seek care at the study site. A fundamental assump-
tion of this method has been that care-seeking patterns among 
typhoid suspects provide an unbiased estimate for care seeking 
among typhoid patients. If individuals with typhoid are more 
(or less) likely to seek medical care, or to seek care at study sites, 
than individuals with other febrile illnesses lasting 3 days, this 
estimate may be biased. Bias in the estimate of this parameter 
in turn leads to biased estimates of enteric fever incidence; spe-
cifically, if typhoid patients are more likely to seek care at study 
sites than patients with other causes of fever, typhoid incidence 
would be overestimated. The converse would also be true.
We hypothesized that individuals with typhoid may have 
more severe symptoms than those with other febrile illnesses 
(eg, viral infections) and therefore may be more likely to present 
to tertiary facilities where surveillance is often conducted. In 
the SEAP study, we therefore introduced two questions aimed 
at assessing the severity of illness among individuals meeting 
the suspected typhoid definition. First, we inquired about how 
many hours the individual spent in bed on their worst day of ill-
ness. Second, we inquired about how many days the individual 
was unable to conduct their usual activities due to illness. We 
asked these questions in both the healthcare utilization survey, 
as well as among culture-confirmed patients and culture-nega-
tive patients at the surveillance site. Additionally, we hypothe-
sized that there may be associations between household wealth 
and typhoid risk, as well as between wealth and healthcare seek-
ing. For bias to occur, variables that are associated with typhoid 
must also be associated with care seeking, and these associa-
tions must be conditionally independent.
Here, we present preliminary data from Nepal to illustrate 
this process of assessing for biases. First, we compared the 
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Figure  2. Relative half-width of the 95% confidence interval (CI) achieved by 
hybrid surveillance as a function of effect sample size (ie, number of households 
with an individual meeting study definition for febrile illness) and fraction of 
patients captured at study sites. Here, incidence is 500 per 100 000 and the popula-
tion size is 500 000. A higher proportion of participants seeking care at the facility 
improves the precision of the adjustment factor estimate as well as the precision 
in the numerator, as more typhoid cases present to the facility. A larger healthcare 
utilization sample size can improve precision in the adjustment factor estimate, 
but greater uncertainty in the incidence estimate remains due to uncertainty in the 
case number.
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odds of seeking care and the odds of having culture-confirmed 
typhoid, according to age, using generalized additive models. 
We found strong and differential associations, which were non-
linear (Figure 3A). These findings clearly support the need for 
age-stratified analyses to minimize biases with this method. We 
found that both severity questions correlated positively with 
both typhoid and care seeking at study site, indicating potential 
bias in the estimate of this factor that would cause overestima-
tion of incidence (Figure 3B). Conversely, we found that wealth-
ier individuals were more likely to have typhoid, but less likely 
to seek care at study sites, a potential bias that would lead to 
underestimation of incidence.
To adjust for these potential biases, we perform a 2-stage 
regression model, in which we first perform multivariable logis-
tic regression to model the relationship between demographic 
and severity factors and typhoid culture positivity using facili-
ty-based data. We then use this model to estimate typhoid cul-
ture positivity among febrile individuals in the catchment area 
by utilizing the distribution of demographic and severity data 
from the healthcare utilization survey. Dividing the observed 
odds of typhoid from the facility data with the predicted odds 
of typhoid in the healthcare utilization survey results in a sum-
mary odds ratio (OR) for typhoid among care seekers compared 
with the general population. This OR can then be applied to the 
adjusted incidence equation above to correct for differences in 
care seeking.
 In the preliminary Nepal data, we observed no statistically 
significant differences in predicted typhoid prevalence between 
those who sought care at study sites and those who did not 
(P  =  .13), due to the offsetting effects of illness severity and 
wealth. However, it should be noted that the absence of differ-
ences does not indicate that there are no differences, but rather 
that the specified model did not identify them, which precludes 
their adjustment in incidence estimates.
To illustrate the potential magnitude of this problem more 
generally, we estimate the bias in incidence estimates as a func-
tion of (1) the OR of typhoid among individuals seeking care 
compared with those not seeking care at study sites; (2) the pro-
portion of the population seeking care at the study sites; and (3) 
the proportion of care-seeking differences (ie, fraction of OR − 1) 
that can be identified and adjusted for by the regression method 
described above (Figure 4). We find that substantial bias (>70%) 
may be seen when the OR for care seeking is high (>2), the pro-
portion seeking care at study site is low (10%), and the propor-
tion adjusted for is low (10%). By contrast, even with substantial 
differences in care seeking (OR of 3), if 50% of the difference 
can be adjusted for in the model and 50% of participants seek 
care at the study site, the bias in incidence estimates would be 
around 15%. These findings highlight the importance in estab-
lishing surveillance at sites with high coverage for febrile illness 
in the catchment population and characterizing differences in 
populations who seek care at study sites and those who do not.
An additional source of bias manifests when individuals, 
meeting enrollment criteria for suspected typhoid, who are 
enrolled at study sites differ from those who are not enrolled 
with respect to typhoid risk. This may occur due to clinicians 
or study staff preferentially enrolling individuals suspected to 
have enteric fever or greater patient propensity to consent for 
blood draw when they have more severe illness. In practice, 
we have observed clinicians discouraging patient enrollment 
in patients whom they believe are unlikely to have enteric 
fever; however, we note that half of culture-confirmed cases 
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occur in patients in whom the primary diagnosis was an 
alternative infection. At some surveillance sites, clinicians 
have reported not enrolling patients whom they are confi-
dent have enteric fever; the bias therefore may act in either 
direction. The primary mechanism for addressing this 
source of bias is through education of clinicians and study 
staff about these data and encouraging consistent application 
of suspected typhoid definitions. If enrollment rates are low 
due to blood culture concerns by patients or clinicians, the 
potential for bias is greater. In such settings, enrollment of 
individuals who decline (or whose clinician advises against) 
blood culture is useful to collect demographic and clinical 
data along with clinician diagnoses. These data may be com-
pared with data from enrolled participants with culture data 
and can be used to generate regression-based estimates of 
typhoid prevalence among individuals who do not have cul-
ture performed.
CONCLUSIONS AND FUTURE DIRECTIONS
Hybrid surveillance represents a lower-cost alternative to 
cohort studies for generating population-based incidence 
estimates for enteric fever and other infectious diseases. For 
this reason, the ongoing SEAP and Severe Enteric Fever in 
Africa (SETA) studies are utilizing this approach. Here, we 
illustrated the framework, methods, and statistical consid-
erations for estimating disease incidence and incorporat-
ing uncertainty in various components of the surveillance 
pyramid. We identify several important considerations in 
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hybrid surveillance design, implementation, and data anal-
ysis that have implications for the precision and accuracy of 
estimates.
First, when the sentinel surveillance sites capture a lower pro-
portion of typhoid cases, this results in lower precision around 
typhoid incidence estimates, which may be only partially offset 
by a larger healthcare utilization survey or longer study. Second, 
we highlight a fundamental assumption in this surveillance 
method, which is that individuals meeting a suspected typhoid 
definition (fever ≥3  days) who present to surveillance sites 
are representative of those who do not present to those sites, 
with respect to their likelihood of having typhoid. In reality, 
we might anticipate that individuals with typhoid, compared 
with those with other illnesses, may have differences in illness 
severity and sociodemographic factors that influence care-seek-
ing patterns. These differences may lead to substantial bias in 
incidence estimates, and the magnitude of this bias is inversely 
proportionate to the proportion of patients who seek care at the 
study site. When a smaller proportion of care-seeking individu-
als are used to infer risk about a larger proportion of individuals 
not seeking care at the study site, the impact of small differences 
is amplified.
We identify 3 potential approaches to minimizing this risk 
of bias. The first is establishing surveillance sites that cover a 
higher proportion of typhoid-like illnesses, which can be done 
by either involving more sites or utilizing a smaller or more 
carefully constructed catchment area, in which the care-seek-
ing proportion is higher. Achieving higher coverage by sentinel 
sites should reduce bias and improve precision of estimates. The 
second is utilizing a more specific case definition for enrollment 
at study sites and inference in the healthcare utilization survey. 
For example, hybrid surveillance has been successfully per-
formed for Japanese encephalitis by utilizing a suspected case 
definition of fever with altered mental status or new-onset sei-
zures, which are relatively uncommon and specific symptoms 
for meningoencephalitis, and there is less likely to be differen-
tial care seeking according to type of encephalitis [13]. A key 
challenge with typhoid is that the disease produces highly non-
specific manifestations that are variable and difficult to distin-
guish from other infections [16–18]. A recent study from Nepal 
demonstrated that even clinician diagnoses have <10% positive 
predictive value [19]. Attempting to select a more specific case 
definition for typhoid (eg, ≥4 or 5  days, or absence of focal 
symptoms) would reduce the number of eligible participants at 
the surveillance sites and in the healthcare utilization survey, 
offsetting efficiency gains, and could potentially introduce addi-
tional biases into the study design by focusing on a narrow set of 
disease manifestations. The most tenable approach to address-
ing potential biases in care seeking may be in collecting data 
to identify sociodemographic and severity factors that predict 
typhoid risk and care seeking, which may enable adjustment as 
outlined above.
Biases may also be introduced by selective enrollment at 
the sentinel surveillance sites, if individuals with typhoid 
are more likely to self-select for consent or be recruited 
by clinicians or study staff. While it may be possible to 
adjust for these biases by characterizing eligible nonen-
rolled patients, the best approach is to educate clinicians 
and study staff about the poor predictive value of empirical 
diagnoses, to maximize recruitment rates. If recruitment 
remains low, the potential for bias is high, and obtaining 
clinical data on eligible individuals who are not cultured 
may be useful for comparison with that of individuals who 
are cultured.
Due to the potential for biases in various components of 
hybrid surveillance, it may be advisable to present multiple 
estimates for disease incidence, highlighting the influence 
of various assumptions (Figure  5). These include crude, 
culture-confirmed incidence, incidence adjusted for cul-
ture sensitivity and facility-based enrollment, incidence 
further adjusted for healthcare utilization, and, finally, 
incidence adjusted for all of these factors along with bias 
correction for differences in care seeking. We note that fur-
ther adjustments may be possible and desirable, if the req-
uisite data are available. For example, blood volume utilized 
for culture and antibiotic use prior to blood culture likely 
influence culture sensitivity; if this relationship is well 
characterized and these data are available in the surveil-
lance system, they may be used to further improve accuracy 
of incidence estimates.
While case-based surveillance remains the only valid source 
of data for typhoid burden assessment at present, we note that 
seroepidemiologic approaches are under development. Most 
of the experience to date has been with measuring immuno-
globulin G to Vi antigen [20–22], which has been imperfect 
and may increasingly be undermined as a marker of disease 
burden due to the rollout of Vi-conjugate vaccines. Alternative 
serologic markers have demonstrated promise for identifying 
acute enteric fever and are being assessed for a potential role in 
seroepidemiology [23, 24].
Hybrid surveillance is not without limitations, but for 
relatively uncommon diseases (<1% per year), it represents 
a powerful and efficient means for generating estimates of 
disease incidence at a fraction of the cost of cohort studies. 
With periodic healthcare utilization assessments alongside 
continuous hospital surveillance, longitudinal monitoring 
of trends in incidence of enteric fever may be maintained 
in resource-limited settings, providing policy-relevant data, 
including in the context of vaccine introduction. Careful 
attention to potential sources of bias in system design, 
implementation, and data analysis can improve the accu-
racy of incidence estimates and result in rigorous and sus-
tainable systems for population-based infectious disease 
surveillance.
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